BBT-877

Generic Name
BBT-877
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Background

BBT-877 is an autotaxin enzyme inhibitor being investigated for the treatment of fibrotic diseases, such as idiopathic pulmonary fibrosis.

Associated Conditions
-
Associated Therapies
-

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-08-02
Last Posted Date
2024-08-13
Lead Sponsor
Bridge Biotherapeutics, Inc.
Target Recruit Count
129
Registration Number
NCT05483907
Locations
🇺🇸

Loyola University Medical Center, Maywood, Illinois, United States

🇦🇺

Institute for Respiratory Health, Nedlands, Western Australia, Australia

🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

and more 41 locations

Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

First Posted Date
2019-10-25
Last Posted Date
2020-01-18
Lead Sponsor
Bridge Biotherapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT04138836
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath